
Background In high-throughput outpatient settings, cycloplegic refraction remains the confirmatory standard for myopia but is resource-intensive. Objectives To evaluate whether a screening-feasible biometric index, the axial length–to–corneal radius ratio (AL/CR; ALCR), can support rapid myopia identification and triage without incorporating diagnostic refractive information. Design Multicenter, clinic-based, cross-sectional study. Methods We enrolled school-aged children and adolescents (6–16 years) presenting to outpatient ophthalmology clinics. Myopia was defined by cycloplegic spherical equivalent (SE) ≤ −0.50 D. The primary association analysis used eye-level generalized estimating equation (GEE) logistic regression with participant-level clustering and robust standard errors, assessing ALCR with and without adjustment for age and sex. Discrimination was evaluated at the participant level using the right eye as the representative eye. Receiver operating characteristic (ROC) analysis estimated AUC, and the optimal cutoff was determined by the Youden index. Internal validation was conducted by participant-level train/test splitting. Results A total of 1,609 participants (3,218 eyes) were included; 1,442 participants had myopia. In GEE models, ALCR was strongly and consistently associated with myopia: per 0.1 increase in ALCR, the odds ratio (OR) was 10.95 (95% CI, 8.15–14.72; P < 0.001) in the unadjusted model and 11.02 (95% CI, 8.17–14.87; P < 0.001) after adjusting for age and sex, while age and sex were not significant. At the participant level, ALCR demonstrated good discrimination (AUC = 0.926; 95% CI, 0.909–0.942) with an optimal cutoff of 3.06, yielding sensitivity 0.817 and specificity 0.890. In internal validation using a training-derived cutoff of 3.07, AUC was 0.932 in the training set and 0.911 in the test set, with comparable sensitivity and specificity. Conclusion ALCR provides a robust, screening-feasible structural signal for myopia triage in a clinic-based pediatric population, supporting a practical single-cutoff rule near 3.0 to prioritize cycloplegic confirmation when diagnostic refractive data are not yet available.
Background Available keratoconus (KC) estimates in Iraq are derived mainly from clinic-based or selected populations and vary across sampling frameworks, diagnostic definitions, and units of analysis. Objectives To summarize study-specific KC and KC-spectrum estimates, demographic and risk-factor evidence, and major sources of heterogeneity without inferring national prevalence. Design Systematic review with primary study-specific and population-stratified synthesis and a secondary exploratory meta-analysis. Data Sources and Methods PubMed, Scopus, Embase, Google Scholar, and the Cochrane Library were searched through December 2025 for English-language observational studies of Iraqi populations published between 2010 and 2025. Two reviewers independently selected studies and extracted data. Methodological quality was assessed using design-appropriate Joanna Briggs Institute checklists. Studies without an eligible prevalence denominator were retained for descriptive or risk-factor synthesis but excluded from quantitative prevalence analysis. The overall six-study model was treated as secondary and exploratory. Sensitivity analyses examined participant/patient-level denominators, clinically established KC, direct topographic/tomographic assessment, and comparable sampling frameworks. Restricted maximum likelihood with Hartung–Knapp adjustment was used for the revised overall model, with DerSimonian–Laird retained as a sensitivity comparator; a 95% prediction interval was also estimated. Results Nine studies were included; six contributed to quantitative synthesis. Study-reported KC/KC-spectrum estimates ranged from 4.1% to 30.2%. Population-stratified estimates were 15.26% (95% CI, 3.74%–45.52%; I 2 =98.89%) in adult ophthalmology/refractive-problem clinic populations and 10.97% (95% CI, 7.50%–15.78%; I 2 =63.51%) in selected pediatric refractive/high-risk populations; one refractive-surgery study reported 4.08% (95% CI, 3.10%–5.36%). Participant/patient-level sensitivity analysis remained highly heterogeneous (I 2 =98.59%). The secondary overall model was not interpreted as a common or national prevalence. One matched case-control study reported associations with eye rubbing, family history, and parental consanguinity. Conclusion Study-specific and population-stratified findings are more informative than a single combined estimate. Representative population-based studies using standardized diagnostic criteria and participant-level reporting are needed.
Background: Age-related macular degeneration (AMD) and diabetic retinopathy (DR) are major causes of vision loss and are both associated with elevated vascular endothelial growth factor (VEGF) levels. Repeated intravitreal anti-VEGF injections may affect intraocular pressure (IOP) and vitreous reflux differently in these conditions. Objectives: This study aimed to compare the effects of repeated anti-VEGF injections (>10) on IOP and vitreous reflux in patients with AMD and DR. Design: Single-center cross-sectional observational comparative study. Methods: Patients diagnosed with AMD or DR who received repeated intravitreal aflibercept or ranibizumab injections were included. IOP was measured before and after injections. Additional evaluated parameters included conjunctival bleb diameter, lens status, and the presence of pseudoexfoliation (PEX). Results: Patients with AMD were significantly older than those with DR ( p < 0.001). Post-injection IOP was significantly lower in the AMD group ( p = 0.023), which was attributed to increased vitreous reflux associated with age-related vitreous liquefaction. Conjunctival bleb diameter was significantly larger in AMD patients ( p = 0.032). No significant differences were observed between the aflibercept and ranibizumab groups. Post-injection IOP was significantly associated with pseudophakia and conjunctival bleb diameter ( p = 0.011 and p < 0.001), but not with the number of injections or the presence of PEX ( p = 0.347 and p = 0.776). Conclusion: Patients with AMD receiving repeated intravitreal aflibercept or ranibizumab injections exhibited larger conjunctival bleb diameters and lower post-injection IOP compared with patients with DR, likely due to increased vitreous reflux related to age-associated vitreous liquefaction. No statistically significant difference in IOP elevation was observed between the aflibercept and ranibizumab treatment groups.
Background The role of dietary nutrients in age-related macular degeneration (AMD) remains debated, particularly high-dose antioxidant supplementation. Objectives To compare recent and habitual dietary nutrient intake in relation to the odds of neovascular AMD (nAMD). Design Hospital-based, individually-recruited case-control study, reported following STROBE. Methods We enrolled 52 treatment-naive patients with nAMD and 50 controls attending tertiary ophthalmology clinics, with diagnosis confirmed by retinal specialists using colour fundus photography and optical coherence tomography. Dietary intake was assessed by semi-quantitative food-frequency questionnaire (SQFFQ) and 24-hour recall, and analysed by multivariable logistic regression with Firth’s penalised likelihood. Primary models were not energy-adjusted; pre-specified sensitivity analyses addressed energy adjustment, alternative specifications and multiple comparisons. Results On 24-hour recall, patients with nAMD reported higher protein, fat, polyunsaturated fatty acid (PUFA) and vitamin E intakes than controls (all p ≤ 0.015). In fully adjusted models, the highest versus lowest tertile of recent PUFA and vitamin E intake carried 10.8-fold (95% CI 2.5–46.2; p = 0.001) and 4.2-fold (95% CI 1.1–15.8; p = 0.04) higher odds of nAMD. Habitual (SQFFQ) odds ratios were non-significant in the fully adjusted model. The PUFA association remained significant with total energy as a covariate (OR 10.5) and after multiple-testing correction, but attenuated after energy-adjusted nutrient residual applied (OR 2.16, 95% CI 0.69-6.81; p = 0.19); vitamin E was specification-sensitive. Conclusion Higher recent intakes of total PUFA and vitamin E, assessed by 24-hour recall, were associated with higher odds of nAMD, whereas habitual SQFFQ intake showed only weak, non-significant trends. Since our data captured total PUFA only and could not distinguish omega-3 from omega-6, these findings are exploratory and hypothesis-generating. They raise a testable question in an under-studied Southeast Asian population: whether the composition of dietary fat, rather than its quantity, matters. Prospective studies with repeated dietary assessment and fatty-acid profiling are needed before causal inference. Registration Not applicable; this observational study was not registered.